Risk of Cardiovascular Disease and Cancer in Patients Initiating JAK Versus IL-4/-13 Inhibitors for Atopic Dermatitis. Zhao SS, Hernandez G, Alam U. Int J Dermatol 2025 Apr 28. doi: 10.1111/ijd.17815.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Zhao SS, Hernandez G, Alam U. Risk of Cardiovascular Disease and Cancer in Patients Initiating JAK Versus IL-4/-13 Inhibitors for Atopic Dermatitis. Int J Dermatol 2025 Apr 28. doi: 10.1111/ijd.17815.
PMID: 40293104